Dyspepsia

• FDA approval · 2010-04-30
  FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  The FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC.

• FDA approval · 2009-08-31
  FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)

  FDA approved a supplemental application for ranitidine by Dr. Reddy's Laboratories Limited.

• FDA approval · 2009-02-27
  FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)

  FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.

• FDA approval · 2008-11-24
  FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)

  FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…

• FDA approval · 2008-06-03
  FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)

  The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved lab…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-02-27
  FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., updating the approved generic product.

• FDA approval · 2007-08-31
  FDA Approved: RANITIDINE — Original Application (Dr. Reddy's Laboratories Limited)

  FDA approved the original ANDA for ranitidine from Dr. Reddy's Laboratories Limited, enabling a generic ranitidine product to be marketed in…